Diagnosing cardiac ischemia with breath-taking speed

Article Abstract:

Amidex Inc. has developed an innovative product for monitoring myocardial ischemia. The Amilyser measures the quantity of adenosine in a patient's exhaled breath and generates the results in five minutes.

Product development, Drug Delivery Systems, Care and treatment, Myocardial ischemia

---

Merger and acquisition activity gains pace

Article Abstract:

This article provides an overview of recent merger and acquisition activities between 1997 and the first half of 2001 within drug companies throughout the world.

Forecasts, trends, outlooks, Marketing procedures, World, Marketing, Cooperative agreement for product marketing, Industry forecasts, Marketing agreements

---

Casting salmonella in a positive light

Article Abstract:

The administration of anticancer drugs with genetically engineered Salmonella bacteria has been licensed by Vion Pharmaceuticals.

Anticancer Drugs, Chemotherapeutic Drugs, Anticancer Immunostimulant Preps, Health aspects, Licensing agreements, Company licensing agreement, Antineoplastic agents, Salmonella, Dosage and administration, Tumors, VION Pharmaceuticals Inc., VION, Tumours, Antimitotic agents, Destruction

Similar abstracts:

• Abstracts: Nosocomial infections rates in adult and pediatric intensive care units in the United States. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis
• Abstracts: Bank on it. Twin Cities' setback: with health systems upping their bids, employers find health care is still a seller's market
• Abstracts: Developing improved observational methods for evaluating therapeutic effectiveness. Does prophylaxis prevent postdental infective endocarditis? a controlled evaluation of protective efficacy
• Abstracts: Economic incentives, health status and health services utilisation. Agency in health care: getting beyond first principles
• Abstracts: Alcohol advertising bans and alcohol abuse: comment. An economic analysis of adult obesity: results from the behavioral risk factor surveillance system

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.